NewToNews

Medical

HealthPlix Technologies raises around Rs 181 crore in Series C funding

Byolaksjl

Mar 16, 2023
Orchid Pharma to raise Rs 500 crore from institutional investors


New Delhi: Health tech startup HealthPlix Technologies on Wednesday said it has raised $22 million (around Rs 181 crore) in Series C funding led by Avataar Venture Partners, SIG Venture Capital and existing investors.

The fresh capital will be used to ramp up product innovation, enhance the technology stack and scale user acquisition efforts.
“At HealthPlix, our vision is to drive better health outcomes at population level. Today, we serve 2.5 percent of the entire Indian population. With these new funds, we aim to cater to 200-250 million more patient lives in an 18-month time frame,” HealthPlix Technologies co-founder & CEO Sandeep Gudibanda said in a statement.
Last year, the Bengaluru-based firm had secured $2 million in debt funding from Blacksoil Ventures.

Read also: HealthPlix raises over Rs 99 crore in Series B funding led by Lightspeed


kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh kkh lisa208 lisa209 lisa210

By olaksjl

Related Post

Medical

AHA: High-deductible, Short-term Health Plans To Blame for Medical Debt

Mar 23, 2023 olaksjl
Medical

Novartis gets CDSCO panel nod for Phase III CT of anticancer drug Ianalumab

Mar 23, 2023 olaksjl
Medical

Animal microbiomes hold the key to new antifungals

Mar 23, 2023 olaksjl

Leave a Reply

Your email address will not be published.

You missed

Viral

Mailed human papillomavirus self-sampling kits are cost-effective

Mar 23, 2023 olaksjl
Medical

AHA: High-deductible, Short-term Health Plans To Blame for Medical Debt

Mar 23, 2023 olaksjl
Viral

Something in the water? Researchers studying large number of late-stage breast cancer cases in Florida county

Mar 23, 2023 olaksjl
Dentistry

Risankizumab shows benefits in psoriasis following suboptimal IL-17 treatment

Mar 23, 2023 olaksjl